Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Clinical and neuroimaging criteria to improve the workflow in transfers for endovascular treatment evaluation.

Requena M, Olivé-Gadea M, Boned S, Ramos A, Cardona P, Urra X, Serena J, Silva Y, Purroy F, Ustrell X, Abilleira S, Tomasello A, Perez de la Ossa N, Molina CA, Ribo M, Rubiera M; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

Int J Stroke. 2019 Sep 10:1747493019874725. doi: 10.1177/1747493019874725. [Epub ahead of print]

PMID:
31506026
2.

Pre-Existing Cerebral Small Vessel Disease Limits Early Recovery in Patients with Acute Lacunar Infarct.

Gómez-Choco M, Mengual JJ, Rodríguez-Antigüedad J, Paré-Curell M, Purroy F, Palomeras E, Fuentes B, Ustrell X, Tembl J, Rodríguez-Yañez M, Castellanos M, Martí-Fabregas J, Serena J.

J Stroke Cerebrovasc Dis. 2019 Aug 5:104312. doi: 10.1016/j.jstrokecerebrovasdis.2019.104312. [Epub ahead of print]

PMID:
31395422
3.

Dissimilar Impact of a Mediterranean Diet and Physical Activity on Anthropometric Indices: A Cross-Sectional Study from the ILERVAS Project.

Sánchez M, Sánchez E, Hernández M, González J, Purroy F, Rius F, Pamplona R, Farràs-Sallés C, Gutiérrez-Carrasquilla L, Fernández E, Bermúdez-López M, Salvador J, Salas-Salvadó J, Lecube A; ILERVAS project collaborators.

Nutrients. 2019 Jun 17;11(6). pii: E1359. doi: 10.3390/nu11061359.

4.

Transfer to the Local Stroke Center versus Direct Transfer to Endovascular Center of Acute Stroke Patients with Suspected Large Vessel Occlusion in the Catalan Territory (RACECAT): Study protocol of a cluster randomized within a cohort trial.

Abilleira S, Pérez de la Ossa N, Jiménez X, Cardona P, Cocho D, Purroy F, Serena J, Román LS, Urra X, Vilaró M, Cortés J, González JA, Chamorro Á, Gallofré M, Jovin T, Molina C, Cobo E, Dávalos A, Ribó M.

Int J Stroke. 2019 May 29:1747493019852176. doi: 10.1177/1747493019852176. [Epub ahead of print]

PMID:
31142219
5.

[Incidence of alarm criteria and attitude towards patients with headache attended in emergency departments].

Vidal-Castello M, Olivart-Parejo M, Abadias-Medrano MJ, Purroy F.

Rev Neurol. 2019 Jun 1;68(11):453-458. doi: 10.33588/rn.6811.2018382. Spanish.

6.

Mediterranean diet, physical activity and subcutaneous advanced glycation end-products' accumulation: a cross-sectional analysis in the ILERVAS project.

Sánchez E, Betriu À, Salas-Salvadó J, Pamplona R, Barbé F, Purroy F, Farràs C, Fernández E, López-Cano C, Mizab C, Lecube A; ILERVAS project investigators.

Eur J Nutr. 2019 May 7. doi: 10.1007/s00394-019-01983-w. [Epub ahead of print]

PMID:
31065845
7.

Age- and Sex-Specific Risk Profiles and In-Hospital Mortality in 13,932 Spanish Stroke Patients.

Purroy F, Vena A, Forné C, de Arce AM, Dávalos A, Fuentes B, Arenillas JF, Krupinski J, Gómez-Choco M, Palomeras E, Martí-Fábregas J, Castillo J, Ustrell X, Tejada J, Masjuan J, Garcés M, Benabdelhak I, Serena J.

Cerebrovasc Dis. 2019;47(3-4):151-164. doi: 10.1159/000500205. Epub 2019 May 3.

PMID:
31055571
8.

Lung function measurements in the prediabetes stage: data from the ILERVAS Project.

Sánchez E, Gutiérrez-Carrasquilla L, Barbé F, Betriu À, López-Cano C, Gaeta AM, Purroy F, Pamplona R, Ortega M, Fernández E, Hernández C, Lecube A, Simó R; ILERVAS Project.

Acta Diabetol. 2019 Sep;56(9):1005-1012. doi: 10.1007/s00592-019-01333-6. Epub 2019 Apr 15.

PMID:
30989377
9.

Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

Sánchez E, Betriu À, Yeramian A, Fernández E, Purroy F, Sánchez-de-la-Torre M, Pamplona R, Miquel E, Kerkeni M, Hernández C, Simó R, Lecube A; ILERVAS project; ILERVAS Project:, Hernández M, Rius F, Polanco D, Barbé F, Torres G, Suárez G, Portero-Otin M, Jové M, Colàs-Campàs L, Benabdelhak I, Farràs C, Ortega M, Manuel Valdivielso J, Bermúdez-López M, Martínez-Alonso M.

J Atheroscler Thromb. 2019 Oct 1;26(10):879-889. doi: 10.5551/jat.47498. Epub 2019 Mar 6.

10.

Effects of Mediterranean Diet and Physical Activity on Pulmonary Function: A Cross-Sectional Analysis in the ILERVAS Project.

Gutiérrez-Carrasquilla L, Sánchez E, Hernández M, Polanco D, Salas-Salvadó J, Betriu À, Gaeta AM, Carmona P, Purroy F, Pamplona R, Farràs C, López-Cano C, Fernández E, Lecube A.

Nutrients. 2019 Feb 3;11(2). pii: E329. doi: 10.3390/nu11020329.

11.

Revalidation of the RACE scale after its regional implementation in Catalonia: a triage tool for large vessel occlusion.

Carrera D, Gorchs M, Querol M, Abilleira S, Ribó M, Millán M, Ramos A, Cardona P, Urra X, Rodríguez-Campello A, Prats-Sánchez L, Purroy F, Serena J, Cánovas D, Zaragoza-Brunet J, Krupinski JA, Ustrell X, Saura J, García S, Mora MÀ, Jiménez X, Dávalos A, Pérez de la Ossa N; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

J Neurointerv Surg. 2019 Aug;11(8):751-756. doi: 10.1136/neurintsurg-2018-014519. Epub 2018 Dec 22.

PMID:
30580284
12.

Telestroke in Catalonia: Increasing Thrombolysis Rate and Avoiding Interhospital Transfers.

López-Cancio E, Ribó M, Cardona P, Serena J, Purroy F, Palomeras E, Aragonès JM, Cocho D, Garcés M, Puiggròs E, Soteras I, Cabanelas A, Villagrasa D, Catena E, Sanjurjo E, López Claverol N, Carrión D, López M, Abilleira S, Dávalos A, Pérez de la Ossa N; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

Cerebrovasc Dis. 2018;46(1-2):66-71. doi: 10.1159/000492124. Epub 2018 Aug 22.

PMID:
30134222
13.

Incidental findings on brain MRI in a cohort of diabetic patients.

Vázquez-Justes D, Sanahuja J, Diez J, Rubinat E, Begué R, Salas C, Vicandi C, Gil MI, Purroy F, Mauricio D.

J Neuroradiol. 2018 Aug 9. pii: S0150-9861(18)30138-X. doi: 10.1016/j.neurad.2018.07.005. [Epub ahead of print]

PMID:
30098369
14.

Minor Hallucinations in Alzheimer's Disease.

Ruiz M, Arias A, Sánchez-Llanos E, Gil MP, López-Ortega R, Dakterzada F, Purroy F, Piñol-Ripoll G.

J Alzheimers Dis. 2018;64(2):543-549. doi: 10.3233/JAD-180234.

PMID:
29889069
15.

Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.

Amarenco P, Lavallée PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, Anticoli S, Audebert H, Bornstein NM, Caplan LR, Correia M, Donnan GA, Ferro JM, Gongora-Rivera F, Heide W, Hennerici MG, Kelly PJ, Král M, Lin HF, Molina C, Park JM, Purroy F, Rothwell PM, Segura T, Školoudík D, Steg PG, Touboul PJ, Uchiyama S, Vicaut É, Wang Y, Wong LKS; TIAregistry.org Investigators.

N Engl J Med. 2018 Jun 7;378(23):2182-2190. doi: 10.1056/NEJMoa1802712. Epub 2018 May 16.

16.

Level of understanding of Alzheimer disease among caregivers and the general population.

Jorge C, Cetó M, Arias A, Blasco E, Gil MP, López R, Dakterzada F, Purroy F, Piñol-Ripoll G.

Neurologia. 2018 May 11. pii: S0213-4853(18)30089-6. doi: 10.1016/j.nrl.2018.03.004. [Epub ahead of print] English, Spanish.

17.

[A systematic review of the characteristics and prognosis of subjects who suffer an embolic stroke of undetermined source].

Molina-Seguin J, Vena AB, Colas-Campas L, Benalbdelhak I, Purroy F.

Rev Neurol. 2018 May 16;66(10):325-330. Spanish.

18.

Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project.

Sánchez E, Lecube A, Betriu À, Hernández C, López-Cano C, Gutiérrez-Carrasquilla L, Kerkeni M, Yeramian A, Purroy F, Pamplona R, Farràs C, Fernández E, Barbé F, Simó R; ILERVAS project, Hernández M, Rius F, Polanco D, de la Torre MS, Torres G, Godoy P, Portero-Otin M, Jové M, Colàs-Compàs L, Benabdelhak I, Miquel E, Ortega M, Valdivielso JM, Bermúdez M, Martínez-Alonso M.

Diabetes Metab. 2018 Apr 13. pii: S1262-3636(18)30079-X. doi: 10.1016/j.diabet.2018.04.002. [Epub ahead of print] No abstract available.

PMID:
29706471
19.

The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism.

Ramos-Araque ME, Rodriguez C, Vecino R, Cortijo Garcia E, de Lera Alfonso M, Sanchez Barba M, Colàs-Campàs L, Purroy F, Arenillas JF, Almeida A, Delgado-Esteban M.

Transl Stroke Res. 2019 Apr;10(2):204-215. doi: 10.1007/s12975-018-0631-1. Epub 2018 Apr 23.

20.

Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors.

Montserrat-Capdevila J, Seminario MA, Godoy P, Marsal JR, Ortega M, Pujol J, Castañ MT, Alsedà M, Betriu À, Lecube A, Portero M, Purroy F, Valdivielso JM, Barbé F.

Med Clin (Barc). 2018 Nov 21;151(10):383-389. doi: 10.1016/j.medcli.2017.12.018. Epub 2018 Mar 7. English, Spanish.

PMID:
29525115
21.

Statins do not increase Markers of Cerebral Angiopathies in patients with Cardioembolic Stroke.

Martí-Fàbregas J, Medrano-Martorell S, Merino E, Prats-Sánchez L, Marín R, Delgado-Mederos R, Camps-Renom P, Martínez-Domeño A, Gómez-Choco M, Lara L, Casado-Naranjo I, Cánovas D, Torres MJ, Freijo M, Calleja A, Bravo Y, Cocho D, Rodríguez-Campello A, Zandio B, Fuentes B, de Felipe A, Llull L, Maestre J, Hernández M, Garcés M, De Arce-Borda AM, Palomeras E, Rodríguez-Yáñez M, Díaz-Maroto I, Serrano M, Fernández-Domínguez J, Sanahuja J, Purroy F, Zedde M, Delgado-Mengual J, Gich I.

Sci Rep. 2018 Jan 24;8(1):1492. doi: 10.1038/s41598-018-20055-3.

22.

Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease.

Masjuan J, Gállego J, Aguilera JM, Arenillas JF, Castellanos M, Díaz F, Portilla JC, Purroy F.

Neurologia. 2018 Jan 9. pii: S0213-4853(17)30366-3. doi: 10.1016/j.nrl.2017.10.013. [Epub ahead of print] English, Spanish.

23.

The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.

Colàs-Campàs L, Royo JL, Montserrat MV, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy F.

Pharmacogenomics J. 2018 Sep;18(5):652-656. doi: 10.1038/s41397-017-0007-z. Epub 2017 Dec 22.

PMID:
29273767
24.

Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Cambray S, Portero-Otin M, Jové M, Torreguitart N, Colàs-Campàs L, Sanz A, Benabdelhak I, Yemisci M, Dalkara T, Dönmez-Demir B, Egea J, Purroy F.

Mol Neurobiol. 2018 Jul;55(7):6193-6200. doi: 10.1007/s12035-017-0827-5. Epub 2017 Dec 21.

PMID:
29270918
25.
26.

Anti-inflammatory approaches to ischaemic stroke prevention.

Kelly PJ, Murphy S, Coveney S, Purroy F, Lemmens R, Tsivgoulis G, Price C.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):211-218. doi: 10.1136/jnnp-2016-314817. Epub 2017 Sep 21. Review.

PMID:
28935831
27.

[Environmental-analytical risk factors influence on the phenotype of amyotrophic lateral sclerosis in a rural setting].

Gonzalez-Mingot C, Romagosa Sanchez-Monge I, Purroy F, Solana-Moga MJ, Peralta-Moncusi S, Lazo-Latorre C, Gil-Villar MP, Brieva L.

Rev Neurol. 2017 Sep 1;65(5):203-208. Spanish.

28.

Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis.

Prats-Sanchez L, Martínez-Domeño A, Camps-Renom P, Delgado-Mederos R, Guisado-Alonso D, Marín R, Dorado L, Rudilosso S, Gómez-González A, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garces M, Abilleira S, Martí-Fàbregas J.

PLoS One. 2017 Jun 22;12(6):e0178284. doi: 10.1371/journal.pone.0178284. eCollection 2017.

29.

Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis.

Purroy F, Vena A, Cánovas D, Cardona P, Cocho D, Cuadrado-Godia E, Chamorro A, Dávalos A, Garcés M, Gomis M, Krupinski J, Palomeras E, Ribó M, Roquer J, Rubiera M, Sanahuja J, Saura J, Serena J, Ustrell X, Vargas M, Benabdelhak I, Abilleira S, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

J Am Geriatr Soc. 2017 Sep;65(9):E117-E122. doi: 10.1111/jgs.14935. Epub 2017 Jun 2.

PMID:
28574595
30.

GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.

Fernández-Cadenas I, Mendióroz M, Giralt D, Nafria C, Garcia E, Carrera C, Gallego-Fabrega C, Domingues-Montanari S, Delgado P, Ribó M, Castellanos M, Martínez S, Freijo M, Jiménez-Conde J, Rubiera M, Alvarez-Sabín J, Molina CA, Font MA, Grau Olivares M, Palomeras E, Perez de la Ossa N, Martinez-Zabaleta M, Masjuan J, Moniche F, Canovas D, Piñana C, Purroy F, Cocho D, Navas I, Tejero C, Aymerich N, Cullell N, Muiño E, Serena J, Rubio F, Davalos A, Roquer J, Arenillas JF, Martí-Fábregas J, Keene K, Chen WM, Worrall B, Sale M, Arboix A, Krupinski J, Montaner J; GRECOS Study Group.

Stroke. 2017 May;48(5):1147-1153. doi: 10.1161/STROKEAHA.116.014322. Epub 2017 Apr 14.

31.

A Current Estimation of the Early Risk of Stroke after Transient Ischemic Attack: A Systematic Review and Meta-Analysis of Recent Intervention Studies.

Valls J, Peiro-Chamarro M, Cambray S, Molina-Seguin J, Benabdelhak I, Purroy F.

Cerebrovasc Dis. 2017;43(1-2):90-98. doi: 10.1159/000452978. Epub 2016 Dec 20. Review.

PMID:
27992865
32.

Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.

Purroy F, Cambray S, Mauri-Capdevila G, Jové M, Sanahuja J, Farré J, Benabdelhak I, Molina-Seguin J, Colàs-Campàs L, Begue R, Gil MI, Pamplona R, Portero-Otín M.

EBioMedicine. 2016 Dec;14:131-138. doi: 10.1016/j.ebiom.2016.11.010. Epub 2016 Nov 9.

33.

Clinical Evolution of Elderly Adults with Ischemic Stroke.

Vena AB, Cambray S, Molina-Seguin J, Colàs-Campàs L, Sanahuja J, Quílez A, González-Mingot C, Gil-Villar MP, Benabdelhak I, Mauri-Capdevila G, Purroy F.

J Am Geriatr Soc. 2016 Oct;64(10):2167-2170. doi: 10.1111/jgs.14426. Epub 2016 Aug 26. No abstract available.

PMID:
27564081
34.

Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies.

Kelly PJ, Albers GW, Chatzikonstantinou A, De Marchis GM, Ferrari J, George P, Katan M, Knoflach M, Kim JS, Li L, Lee EJ, Olivot JM, Purroy F, Raposo N, Rothwell PM, Sharma VK, Song B, Tsivgoulis G, Walsh C, Xu Y, Merwick A.

Lancet Neurol. 2016 Nov;15(12):1238-1247. doi: 10.1016/S1474-4422(16)30236-8. Epub 2016 Oct 11.

PMID:
27751555
35.

Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry.

Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico A, Benavente Fernández L, Masjuan Vallejo J, Gállego Culleré J, Freijó Guerrero MDM, Egido J, Gómez Sánchez JC, Martínez Domeño A, Purroy F, Vives Pastor B, Rodríguez Yáñez M, Vivancos J; en representación del grupo de investigadores del estudio TAC Registry.

Neurologia. 2018 Sep;33(7):419-426. doi: 10.1016/j.nrl.2016.07.005. Epub 2016 Sep 16. English, Spanish.

36.

Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.

Prats-Sánchez L, Camps-Renom P, Sotoca-Fernández J, Delgado-Mederos R, Martínez-Domeño A, Marín R, Almendrote M, Dorado L, Gomis M, Codas J, Llull L, Gómez González A, Roquer J, Purroy F, Gómez-Choco M, Cánovas D, Cocho D, Garces M, Abilleira S, Martí-Fàbregas J; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

Stroke. 2016 Aug;47(8):2003-9. doi: 10.1161/STROKEAHA.116.013952. Epub 2016 Jul 12. Erratum in: Stroke. 2017 Oct;48(10 ):e320.

PMID:
27406103
37.

Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy.

Sanahuja J, Alonso N, Diez J, Ortega E, Rubinat E, Traveset A, Alcubierre N, Betriu À, Castelblanco E, Hernández M, Purroy F, Arcidiacono MV, Jurjo C, Fernández E, Puig-Domingo M, Groop PH, Mauricio D.

Diabetes Care. 2016 Sep;39(9):1614-20. doi: 10.2337/dc15-2671. Epub 2016 Jun 8.

PMID:
27281772
38.

The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage.

Martí-Fàbregas J, Prats-Sánchez L, Martínez-Domeño A, Camps-Renom P, Marín R, Jiménez-Xarrié E, Fuentes B, Dorado L, Purroy F, Arias-Rivas S, Delgado-Mederos R.

PLoS One. 2016 Jun 8;11(6):e0156992. doi: 10.1371/journal.pone.0156992. eCollection 2016.

39.

[Update on post-stroke depression: posing new challenges in patients with a minor stroke or transient ischaemic attack].

Carnes-Vendrell A, Deus-Yela J, Molina-Seguin J, Pifarre-Paredero J, Purroy F.

Rev Neurol. 2016 May 16;62(10):460-7. Review. Spanish.

40.

Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project.

Betriu À, Farràs C, Abajo M, Martinez-Alonso M, Arroyo D, Barbé F, Buti M, Lecube A, Portero M, Purroy F, Torres G, Valdivielso JM, Fernández E.

Nefrologia. 2016 Jul-Aug;36(4):389-96. doi: 10.1016/j.nefro.2016.02.008. Epub 2016 Apr 1. English, Spanish.

41.

Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.

Pérez de la Ossa N, Abilleira S, Dorado L, Urra X, Ribó M, Cardona P, Giralt E, Martí-Fàbregas J, Purroy F, Serena J, Cánovas D, Garcés M, Krupinski J, Pellisé A, Saura J, Molina C, Dávalos A, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2016 May;47(5):1381-4. doi: 10.1161/STROKEAHA.116.013069. Epub 2016 Mar 31.

PMID:
27032445
42.

The determination of copeptin levels helps management decisions among transient ischaemic attack patients.

Purroy F, Suárez-Luis I, Cambray S, Farré J, Benabdelhak I, Mauri-Capdevila G, Sanahuja J, Quílez A, Begué R, Gil MI, Molina-Seguin J, Torreguitart N.

Acta Neurol Scand. 2016 Aug;134(2):140-7. doi: 10.1111/ane.12523. Epub 2015 Oct 16.

PMID:
26471428
43.

B-type natriuretic peptides help in cardioembolic stroke diagnosis: pooled data meta-analysis.

Llombart V, Antolin-Fontes A, Bustamante A, Giralt D, Rost NS, Furie K, Shibazaki K, Biteker M, Castillo J, Rodríguez-Yáñez M, Fonseca AC, Watanabe T, Purroy F, Zhixin W, Etgen T, Hosomi N, Jafarian Kerman SR, Sharma JC, Knauer C, Santamarina E, Giannakoulas G, García-Berrocoso T, Montaner J.

Stroke. 2015 May;46(5):1187-95. doi: 10.1161/STROKEAHA.114.008311. Epub 2015 Mar 12. Review.

PMID:
25765726
44.

Applicability of the SPAN-100 index in a prospective and contemporary cohort of patients treated with intravenous rtPA in Catalonia.

Abilleira S, Ribera A, Quesada H, Rubiera M, Castellanos M, Vargas M, Gomis M, Krupinski J, Delgado-Mederos R, Gómez-Choco M, Giralt-Steinhauer E, Garcia MC, Pellisé A, Purroy F, Garcés M, Gallofré M; en nombre del Consorcio Catalán de Código Ictus y Reperfusión.

Neurologia. 2016 Nov - Dec;31(9):592-598. doi: 10.1016/j.nrl.2014.10.007. Epub 2014 Dec 24. English, Spanish.

45.

Clinical characteristics and outcome of the capsular warning syndrome: a multicenter study.

Camps-Renom P, Delgado-Mederos R, Martínez-Domeño A, Prats-Sánchez L, Cortés-Vicente E, Simón-Talero M, Arboix A, Ois Á, Purroy F, Martí-Fàbregas J.

Int J Stroke. 2015 Jun;10(4):571-5. doi: 10.1111/ijs.12432. Epub 2014 Dec 18.

PMID:
25523826
46.

Metabolomics predicts stroke recurrence after transient ischemic attack.

Jové M, Mauri-Capdevila G, Suárez I, Cambray S, Sanahuja J, Quílez A, Farré J, Benabdelhak I, Pamplona R, Portero-Otín M, Purroy F.

Neurology. 2015 Jan 6;84(1):36-45. doi: 10.1212/WNL.0000000000001093. Epub 2014 Dec 3.

47.

Functional outcome after primary endovascular therapy or IV thrombolysis alone for stroke. An observational, comparative effectiveness study.

Abilleira S, Ribera A, Dávalos A, Ribó M, Chamorro A, Cardona P, Molina CA, Martínez-Yélamos A, Urra X, Dorado L, Roquer J, Martí-Fàbregas J, Aja L, Tomasello A, Castaño C, Blasco J, Cánovas D, Castellanos M, Krupinski J, Guimaraens L, Perendreu J, Ustrell X, Purroy F, Gómez-Choco M, Baiges JJ, Cocho D, Saura J, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Cerebrovasc Dis. 2014;38(5):328-36. doi: 10.1159/000368433. Epub 2014 Nov 21.

PMID:
25428822
48.

Prediction of myocardial infarction in patients with transient ischaemic attack.

Vilanova MB, Mauri-Capdevila G, Sanahuja J, Quilez A, Piñol-Ripoll G, Begué R, Gil MI, Codina-Barios MC, Benabdelhak I, Purroy F.

Acta Neurol Scand. 2015 Feb;131(2):111-9. doi: 10.1111/ane.12291. Epub 2014 Oct 10.

PMID:
25302931
49.

How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up.

Purroy F, Jiménez Caballero PE, Gorospe A, Torres MJ, Alvarez-Sabin J, Martínez-Sánchez P, Cánovas D, Freijo M, Egido JA, Ramírez-Moreno JM, Alonso-Arias A, Rodríguez-Campello A, Casado-Naranjo I, Martí-Fàbregas J, Silva Y, Cardona P, Morales A, García-Pastor A, Arenillas JF, Segura T, Jiménez C, Masjuán J.

J Neurol. 2014 Aug;261(8):1614-21. doi: 10.1007/s00415-014-7390-z. Epub 2014 Jun 10.

PMID:
24912470
50.

Letter by Purroy and Kelly regarding article, "A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics".

Purroy F, Kelly PJ.

Stroke. 2014 May;45(5):e87. doi: 10.1161/STROKEAHA.114.004896. Epub 2014 Apr 10. No abstract available.

PMID:
24723317

Supplemental Content

Loading ...
Support Center